Volume 8, Number 11—November 2002
THEME ISSUE
Tuberculosis Genotyping
Tuberculosis Genotyping Network, United States
Use of DNA Fingerprinting To Investigate a Multiyear, Multistate Tuberculosis Outbreak
Table 1
Characteristic | New Jersey n=5 | New York City n=10 | Baltimore n=18 | Maryland n=6 | Total n=39 (%) |
---|---|---|---|---|---|
Culture-positive | 4 | 10 | 17 | 5 | 36 (92) |
Sputum smear–positive | 1 | 4 | 9 | 3 | 17 (44) |
Disease site | |||||
Pulmonary only | 2 | 5 | 11 | 4 | 22 (56) |
Exrapulmonary only | 0 | 2 | 4 | 2 | 8 (21) |
Pulmonary-extrapulmonary | 3 | 3 | 3 | 0 | 9 (23) |
Cavitary disease | 0 | 0 | 2 | 1 | 3 (8) |
HIV status | |||||
Positive | 2 | 7 | 11 | 1 | 21 (54) |
Unknown | 1 | 0 | 1 | 1 | 3 (8) |
Deceaseda | 2 | 2 | 1 | 1 | 6 (15) |
aFour of six patients died within 3 months of their TB diagnosis.
1 PDM, TRS, CRD, BK, CLW, WAC, DXH, KLS, and RR were involved in the conception and design of various phases (epidemiologic and laboratory methods) of this investigation. All coauthors were responsible for collection of either epidemiologic or molecular genotyping data. Analysis and interpretation of the data were primarily performed by PDM, TRS, and RR. All coauthors participated in preparation and critical review of the manuscript.
Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.